Ross, Charles & Son’s Laboratory Paddle Blender offers advanced features for automated powder blending and liquid spraying operation with recipe management.
Ross, Charles & Son’s Laboratory Paddle Blender offers advanced features for automated powder blending and liquid spraying operation with recipe management. Features include full vacuum capability, a pneumatic powder charging port, and a liquid delivery spray system to promote batch-to-batch consistency. The 1-ft3, 42P-1SS model is constructed entirely of United States stainless steel type 304 with 150-grit interior finish and driven by a 1-hp, totally enclosed, fan-cooled motor.
Touchscreen programmable logic controller recipe controls are housed inside a National Electrical Manufacturers Association-classified 4X stainless steel enclosure, allowing for indoor or outdoor use. The company states that an interchangeable ribbon agitator can be supplied with any new paddle blender for increased versatility. Both paddle and ribbon agitators are used in the preparation of dry solid-solid mixes and can accommodate minor liquid additions.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.